Boehringer Ingelheim Animal Health

Error creating thumbnail:

Merial logo

Boehringer Ingelheim Animal Health is a prominent division of the global pharmaceutical company Boehringer Ingelheim, focused on the development, production, and marketing of pharmaceuticals and healthcare products for animals. The division plays a critical role in improving the health and well-being of animals across the globe, encompassing a wide range of species including pets, livestock, and horses.

History

Boehringer Ingelheim initiated its journey into animal health in the early 20th century, with its roots deeply embedded in the broader mission of the parent company to create value through innovation in the healthcare sector. Over the years, Boehringer Ingelheim Animal Health has grown through strategic acquisitions and research advancements, solidifying its position as a leader in the animal health industry.

Products and Services

Boehringer Ingelheim Animal Health offers a comprehensive portfolio of products and services designed to meet the diverse needs of animals and their caretakers. This includes vaccines, parasiticides, therapeutics, and digital solutions aimed at preventing and treating a wide array of diseases. The division is particularly renowned for its contributions to swine health, poultry health, and the well-being of companion animals.

Vaccines

Vaccines constitute a significant part of Boehringer Ingelheim Animal Health's product lineup, providing immunity against various infectious diseases in animals. These vaccines are developed using cutting-edge technology and rigorous research to ensure efficacy and safety.

Parasiticides

Parasiticides are another critical offering, designed to protect animals from parasites such as fleas, ticks, and worms. These products are essential for maintaining the health and comfort of pets and livestock.

Therapeutics

The division also develops therapeutics for the treatment of a wide range of conditions, including pain management, cardiovascular diseases, and respiratory issues among animals. These products are a testament to Boehringer Ingelheim Animal Health's commitment to advancing animal healthcare.

Research and Development

Research and development (R&D) are at the core of Boehringer Ingelheim Animal Health's operations. The division invests heavily in R&D to pioneer new treatments, vaccines, and healthcare solutions that can address unmet needs in animal health. This commitment to innovation is driven by a deep understanding of the challenges faced by animals and those who care for them.

Sustainability and Responsibility

Boehringer Ingelheim Animal Health is also dedicated to sustainability and corporate responsibility. The division's efforts in this area focus on reducing its environmental footprint, ensuring the ethical treatment of animals, and supporting communities around the world.

Conclusion

Boehringer Ingelheim Animal Health stands as a testament to the commitment of Boehringer Ingelheim to enhance the health and well-being of animals. Through its extensive product portfolio, innovative research, and dedication to sustainability, the division continues to make significant contributions to animal health, benefiting animals, their caretakers, and society at large.